Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ, Hanna WM, Chapman JA, Trudeau ME, Lickley HL, Mobbs BG, Murray D, Pritchard KI, Sawka CA, McCready DR, Marks A. Kahn HJ, et al. Among authors: pritchard ki. Breast J. 2006 Jul-Aug;12(4):294-301. doi: 10.1111/j.1075-122X.2006.00267.x. Breast J. 2006. PMID: 16848838
HER2/neu in systemic therapy for women with breast cancer: a systematic review.
Dhesy-Thind B, Pritchard KI, Messersmith H, O'Malley F, Elavathil L, Trudeau M. Dhesy-Thind B, et al. Among authors: pritchard ki. Breast Cancer Res Treat. 2008 May;109(2):209-29. doi: 10.1007/s10549-007-9656-y. Epub 2007 Jul 17. Breast Cancer Res Treat. 2008. PMID: 17636396 Review.
Triple-negative breast cancer: clinical features and patterns of recurrence.
Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA. Dent R, et al. Among authors: pritchard ki. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34. doi: 10.1158/1078-0432.CCR-06-3045. Clin Cancer Res. 2007. PMID: 17671126
Review of the clinical studies using the 21-gene assay.
Kelly CM, Warner E, Tsoi DT, Verma S, Pritchard KI. Kelly CM, et al. Among authors: pritchard ki. Oncologist. 2010;15(5):447-56. doi: 10.1634/theoncologist.2009-0277. Epub 2010 Apr 26. Oncologist. 2010. PMID: 20421266 Free PMC article. Review.
Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.
Pritchard KI, Burris HA 3rd, Ito Y, Rugo HS, Dakhil S, Hortobagyi GN, Campone M, Csöszi T, Baselga J, Puttawibul P, Piccart M, Heng D, Noguchi S, Srimuninnimit V, Bourgeois H, Gonzalez Martin A, Osborne K, Panneerselvam A, Taran T, Sahmoud T, Gnant M. Pritchard KI, et al. Clin Breast Cancer. 2013 Dec;13(6):421-432.e8. doi: 10.1016/j.clbc.2013.08.011. Clin Breast Cancer. 2013. PMID: 24267730 Free article. Clinical Trial.
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.
Clemons MJ, Cochrane B, Pond GR, Califaretti N, Chia SK, Dent RA, Song X, Robidoux A, Parpia S, Warr D, Rayson D, Pritchard KI, Levine MN. Clemons MJ, et al. Among authors: pritchard ki. Breast Cancer Res Treat. 2014 Jul;146(1):153-62. doi: 10.1007/s10549-014-3015-6. Epub 2014 Jun 13. Breast Cancer Res Treat. 2014. PMID: 24924416 Clinical Trial.
344 results